Baker Jones M

Hammersmith Medicines Research, London, United Kingdom.

1 paper

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.

James E, Erritzoe D, Benway T +12